Summit Therapeutics SMMT
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q3 | 21.90 | 103.78 | -0.07 | -58,378 | -56 | |
| 2024Q2 | 7.80 | 98.73 | -0.09 | -59,617 | -60 | |
| 2024Q1 | 4.14 | 97.51 | -0.06 | -42,389 | -43 | |
| 2023Q4 | 2.61 | 99.02 | -0.01 | -36,210 | -37 | |
| 2023Q3 | 1.87 | 96.35 | 0.05 | -20,492 | -21 | |
| 2023Q2 | 2.51 | 107.32 | 0.40 | -15,794 | -15 | |
| 2023Q1 | 1.75 | 99.04 | -1.43 | -537,154 | -542 | |
| 2022Q4 | 4.25 | 105.56 | -0.04 | -20,299 | -19 | |
| 2022Q3 | 1.19 | 79.21 | -0.10 | -16,940 | -21 | |
| 2022Q2 | 1.00 | 75.68 | -0.12 | -12,692 | -17 | |
| 2022Q1 | 2.45 | 103.56 | -0.15 | -22,158 | -21 | |
| 2021Q4 | 2.69 | 96.12 | 0.00 | -26,047 | -27 | |
| 2021Q3 | 5.01 | 99.42 | -0.19 | -19,486 | -20 | |
| 2021Q2 | 7.46 | 97.19 | -0.27 | -23,730 | -24 | |
| 2021Q1 | 5.87 | 96.77 | -0.21 | -16,923 | -17 | |
| 2020Q4 | 4.70 | 85.21 | -0.18 | -11,556 | -14 | |
| 2020Q3 | 3.44 | -0.26 | -17,357 | -18 | ||
| 2020Q2 | 2.97 | -0.23 | -15,356 | -15 | ||
| 2014Q4 | 100.25 | -4,417 | -4 |